본문으로 건너뛰기
cccskills
무료GitHub에 공개

jes-pa-treatment-selection

Determines whether to recommend adrenalectomy or mineralocorticoid receptor antagonists for primary aldosteronism based on PA subtype and patient/surgical factors. Triggered after subtype confirmation when clinicians ask “Should this patient have surgery or medical treatment?” or discuss treatment options with the patient.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

실행 점수 미검증

설치 방법 보기

포함된 파일(1)

  • SKILL.md2.7 KB

SKILL.md(원문)

설치하기 전에 에이전트에게 전달되는 지시 내용을 확인할 수 있습니다.

Select between adrenalectomy and medical therapy for PA management

STEP 1 — Gather Information

Collect AVS results (or alternative subtype diagnosis) to determine unilateral vs bilateral PA, patient age, serum potassium, PAC, adrenal CT findings, patient preference for surgery, and surgical contraindications.
Action: Proceed to subtype classification.

STEP 2 — Rule In / Rule Out

Is PA unilateral? If yes, proceed to evaluate surgical suitability; if no (bilateral), recommend medical therapy with MRAs.
Action: For bilateral PA, start MRA therapy; for unilateral PA, move to candidacy assessment.

STEP 3 — Classify or Stratify

Among unilateral PA patients, assess surgical candidacy: age <35 years, spontaneous hypokalemia (<3.5 mEq/L), PAC >300 pg/mL, unilateral adrenal tumor on CT, patient desire for surgery, and absence of major surgical comorbidities.
Action: Classify as surgical candidate if criteria met; otherwise classify as non‑surgical candidate.

STEP 4 — Decide

If surgical candidate, recommend adrenalectomy; if non‑surgical candidate (unilateral PA not meeting criteria) or bilateral PA, recommend medical therapy with MRAs.
Action: Initiate adrenalectomy or MRA therapy accordingly.

Clinical Guardrails / Mimics / Pitfalls

Do not recommend adrenalectomy without confirming unilateral subtype; avoid bypassing AVS in patients >35 years or lacking typical features (hypokalemia, high PAC, unilateral tumor); respect patient refusal of surgery even when criteria are met; do not initiate MRAs in bilateral PA without subtype confirmation; monitor for postoperative hyperkalemia and adrenal insufficiency if cortisol co‑secretion is suspected; avoid MRAs in patients with severe renal impairment or hyperkalemia risk without appropriate precautions.

Concrete Clinical Example

A 32‑year‑old woman with spontaneous hypokalemia (K⁺ 3.2 mEq/L), PAC 350 pg/mL, ARR 650, and a 1.8 cm left adrenal adenoma on CT undergoes AVS showing lateralization index > 4 with ACTH. She meets all surgical criteria and desires curative treatment. Laparoscopic left adrenalectomy is performed, normalizing BP and K⁺ postoperatively.

Source: Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021, Japan Endocrine Society, 2021

리뷰

아직 리뷰가 없습니다. 사용해 본 소감을 남겨 주세요.

댓글

로그인 없이 쓸 수 있습니다. 사용 후기, 질문, 작동하지 않은 환경 등을 편하게 남겨 주세요.

아직 댓글이 없습니다. 첫 댓글을 남겨 보세요.

보내면 바로 공개됩니다. 이메일 주소나 전화번호 같은 개인 정보는 쓰지 마세요. URL은 2개까지입니다.

0 / 1,000자

이 양식은 reCAPTCHA로 보호되며 Google 개인정보처리방침 및 서비스 약관이 적용됩니다.

같은 저장소의 스킬

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

dromlakhani의 스킬 모두 보기

이 스킬의 문제 신고